ARCHIVES

Skipper’s Impact: Drugs Curing 40,000 a Year

This article is from The Cancer Letter archive.

Vol. 07 No. 13 | March 27, 1981

Download PDF Visit The Full Archive

Related Articles

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

EMEND Improved Emesis In Men And Women, Trials Find

December 26, 2003

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986